EUPRAXIA PHARMACEUTICALS INC (EPRX.CA) Stock Cash Flow
TSX:EPRX - Toronto Stock Exchange - CA29842P1053 - Common Stock - Currency: CAD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -22.57M | -28.97M | -23.92M | -23.37M | -4.01M | |||
| Depreciation Amortization | 36.89K | 112.88K | 190.00K | 110.00K | 120.00K | |||
| Change In Working Capital | -1.77M | 5.35M | 2.07M | -210.00K | 1.56M | |||
| Other non cash items | -602.88K | 2.82M | 2.87M | 8.83M | 1.93M | |||
| OPERATING CASH FLOW | -24.91M | -20.68M | -18.78M | -14.64M | -400.00K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -103.29K | -73.38K | -310.00K | -430.00K | 0.00 | |||
| Other Investing Activity | N/A | 0.00 | 9.01M | -14.02M | 20.00K | |||
| INVESTING CASH FLOW | -74.78K | -73.38K | 8.70M | -14.45M | 20.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -9.13M | -144.44K | -190.00K | 12.08M | -390.00K | |||
| Stock Issued/Repurchased | 15.90M | 21.16M | 13.71M | 37.83M | N/A | |||
| Other Financing Activity | N/A | N/A | N/A | 0.00 | -240.00K | |||
| FINANCING CASH FLOW | 6.76M | 21.01M | 13.52M | 49.92M | -630.00K | |||
| Exchange Rate Effect | 141.88K | 821.40K | 400.00K | -80.00K | N/A | |||
| CHANGE IN CASH | -18.08M | 1.08M | 3.84M | 20.75M | -1.01M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -24.91M | -20.68M | -18.78M | -14.64M | -400.00K | |||
| Capital Expenditure | -103.29K | -73.38K | -310.00K | -430.00K | 0.00 | |||
| FREE CASH FLOW | -25.01M | -20.76M | -19.09M | -15.07M | -400.00K | |||
All data in USD